Table 2.
Individual hormonal and radiological data of patients, both cured and partially cured at first follow-up, who showed recurrence of disease after surgery
| Sex | Age at diagnosis | After TNS surgery | At time of recurrence | MRI imaging at follow-up | Time of recurrence (months after TNS) | |
|---|---|---|---|---|---|---|
| Patients cured at first follow-up after surgery | ||||||
| 1 | M | 59 |
IGF1 -0.15 SDS GHn 0.09 µg/L |
IGF1 5.61 SDS GHn 1.27 µg/L |
Stable residual tumor | 15 |
| 2 | F | 23 |
IGF1 0.93 SDS GHn 0.06 µg/L |
IGF1 5.07 SDS GHn 0.18 µg/L |
Empty sella | 157.8 |
| 3 | M | 50 |
IGF1 1.12 SDS GHn 0.20 µg/L |
IGF1 3.85 SDS GHn 0.16 µg/L |
Stable residual tumor | 134 |
| 4 | M | 41 |
IGF1 0.26 SDS GHr 0.8 µg/L |
IGF1 4.72 SDS GHn 0.50 µg/L |
Stable residual tumor | 28 |
| 5 | F | 36 |
IGF1 -0.40 SDS GHn 0.11 µg/L |
IGF1 3.25 SDS NA |
NA | 5 |
| Patients partially cured at first follow-up after surgery | ||||||
| 6 | F | 47 |
IGF1 2.01 SDS GHn 0.47 µg/L |
IGF1 2.75 SDS GHn 0.60 µg/L |
Empty sella | 12 |
| 7 | M | 74 |
IGF1 0.76 SDS GHn 2.20 µg/L |
IGF1 3.62 SDS GHn 0.50 µg/L |
Stable residual tumor | 37 |